ID   LSCTRi001-A
AC   CVCL_VE29
SY   LSCTR-LiPSC-6
DR   hPSCreg; LSCTRi001-A
DR   SKIP; SKIP002983
DR   Wikidata; Q54903100
RX   PubMed=29310059;
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; 2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Homozygous; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (PubMed=29310059).
CC   Sequence variation: Mutation; HGNC; 2638; CYP3A5; Simple; c.219-237G>A; ClinVar=VCV000226021; Zygosity=Homozygous; Note=Aberrant splice site. CYP3A5*3C allele (PubMed=29310059).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
RX   PubMed=29310059; DOI=10.1016/j.scr.2017.12.014;
RA   Lee J., Woo D.-H., Park H.-J., Park K., Ko D.S., Kim J.-H.;
RT   "Human induced pluripotent stem cell line with cytochrome P450 enzyme
RT   polymorphism (CYP2C19*2/CYP3A5*3C) generated from lymphoblastoid
RT   cells.";
RL   Stem Cell Res. 27:34-37(2018).
//